Insmed (INSM)
(Delayed Data from NSDQ)
$74.50 USD
+0.07 (0.09%)
Updated Jul 25, 2024 04:00 PM ET
After-Market: $74.48 -0.02 (-0.03%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth D Momentum F VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
INSM 74.50 +0.07(0.09%)
Will INSM be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for INSM based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for INSM
Insmed (INSM) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Insmed (INSM) Stock Soars 118% on Upbeat Lung Disease Drug Data
INSM: What are Zacks experts saying now?
Zacks Private Portfolio Services
Insmed (INSM) Beats on Q1 Earnings, Posts Upbeat Pipeline Updates
Insmed (INSM) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
Insmed (INSM) Reports Q1 Loss, Lags Revenue Estimates
Other News for INSM
Artisan Mid Cap Fund Q2 2024 Commentary
Russell rotation: YTD market capitalizations swelling for small-caps
Here's How Much $100 Invested In Insmed 10 Years Ago Would Be Worth Today
ClearBridge Small Cap Growth Strategy Q2 2024 Commentary
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)